During the past decade, Prisma Health Opthalmology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Prisma Health Opthalmology" are "Corneal Ulcer" (2 trials) and "Keratitis" (2 trials). Many other conditions were trialed in "Prisma Health Opthalmology" in a lesser frequency.

Most popular intervention types in "Prisma Health Opthalmology" are "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "PXL Platinum 330 system + Riboflavin 0.25% TE Solution" (1 trials), "Sham CXL + Artificial Tears" (1 trials), "Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution" (1 trials) and "Standard of Care Therapy + Sham CXL + Artificial Tears" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Opthalmology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Prisma Health Opthalmology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Prisma Health Opthalmology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Opthalmology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".